DNA Sequencing Prior to HCT Identifies Patients at Risk of Poor AML Outcomes
A study of patients with acute myeloid leukemia (AML) in first remission found that the presence of certain variants indicative of measurable residual disease ahead of allogeneic hematopoietic cell transplant (HCT) was associated with relapse and worse survival.
Source: ajmc.com